Prognostic value of extracellular matrix gene mutations and expression in multiple myeloma

被引:6
作者
Evers, Marietheres [1 ]
Schreder, Martin [2 ,3 ]
Stuehmer, Thorsten [4 ]
Jundt, Franziska [2 ,4 ]
Ebert, Regina [5 ]
Hartmann, Tanja Nicole [6 ,7 ]
Altenbuchinger, Michael [8 ]
Rudelius, Martina [1 ,9 ]
Kuric, Martin [5 ]
Rindt, Wyonna Darleen [2 ]
Steinbrunn, Torsten [2 ,10 ]
Langer, Christian [11 ]
Heredia-Guerrero, Sofia Catalina [1 ]
Einsele, Hermann [2 ]
Bargou, Ralf Christian [4 ]
Rosenwald, Andreas [1 ,4 ]
Leich, Ellen [1 ,4 ]
机构
[1] Univ Wurzburg, Inst Pathol, Wurzburg, Germany
[2] Univ Hosp Wurzburg, Dept Internal Med 2, Wurzburg, Germany
[3] Klin Ottakring, Dept Med 1, Vienna, Austria
[4] Univ Hosp Wurzburg, Comprehens Canc Ctr Mainfranken, Wurzburg, Germany
[5] Univ Wurzburg, Dept Musculoskeletal Tissue Regenerat, Wurzburg, Germany
[6] Univ Freiburg, Med Ctr, Dept Internal Med 1, Freiburg, Germany
[7] Univ Freiburg, Fac Med, Freiburg, Germany
[8] Univ Med Ctr Gottingen, Dept Med Bioinformat, Gottingen, Germany
[9] Ludwig Maximilians Univ Munchen, Inst Pathol, Munich, Germany
[10] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA
[11] Univ Hosp Ulm, Dept Internal Med 3, Ulm, Germany
关键词
DRUG-RESISTANCE; CELL-ADHESION;
D O I
10.1038/s41408-023-00817-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:5
相关论文
共 50 条
[41]   The Drosophila Hox gene Ultrabithorax controls appendage shape by regulating extracellular matrix dynamics [J].
De las Heras, Joseprime M. ;
Garcia-Cortes, Celia ;
Foronda, David ;
Carlos Pastor-Pareja, Jose ;
Shashidhara, L. S. ;
Sanchez-Herrero, Ernesto .
DEVELOPMENT, 2018, 145 (13)
[42]   Prognostic value of integrin αV expression and localization pattern in invasive breast carcinomas [J].
Cerqueira, Otto Luiz Dutra ;
Botelho, Mayara Carolline Silva ;
Fiore, Ana Paula Zen Petisco ;
Osorio, Cynthia Aparecida Bueno de Toledo ;
Tomasin, Rebeka ;
Morais, Mauro Cesar Cafundo ;
Lopez, Rossana Veronica Mendoza ;
Cardoso, Elaine Cristina ;
Vilella-Arias, Santiago Andres ;
Reis, Eduardo Moraes ;
Bruni-Cardoso, Alexandre .
NEOPLASIA, 2022, 30
[43]   Therapeutic status and the prospect of CRISPR/Cas9 gene editing in multiple myeloma [J].
Hong, Lemin ;
Zhang, Chenlu ;
Jiang, Yijing ;
Liu, Haiyan ;
Huang, Hongming ;
Guo, Dan .
FUTURE ONCOLOGY, 2020, 16 (16) :1125-1136
[44]   Identification of KDM4C as a gene conferring drug resistance in multiple myeloma [J].
Zhang, Na ;
Lan, Ruilong ;
Chen, Yingyu ;
Hu, Jianda .
OPEN LIFE SCIENCES, 2024, 19 (01)
[45]   PSMB7 Is a Key Gene Involved in the Development of Multiple Myeloma and Resistance to Bortezomib [J].
Wu, Dong ;
Miao, Jiyu ;
Hu, Jinsong ;
Li, Fangmei ;
Gao, Dandan ;
Chen, Hongli ;
Feng, Yuandong ;
Shen, Ying ;
He, Aili .
FRONTIERS IN ONCOLOGY, 2021, 11
[46]   Bortezomib overcomes cell adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma [J].
Noborio-Hatano, K. ;
Kikuchi, J. ;
Takatoku, M. ;
Shimizu, R. ;
Wada, T. ;
Ueda, M. ;
Nobuyoshi, M. ;
Oh, I. ;
Sato, K. ;
Suzuki, T. ;
Ozaki, K. ;
Mori, M. ;
Nagai, T. ;
Muroi, K. ;
Kano, Y. ;
Furukawa, Y. ;
Ozawa, K. .
ONCOGENE, 2009, 28 (02) :231-242
[47]   Bortezomib overcomes cell adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma [J].
K Hatano ;
J Kikuchi ;
M Takatoku ;
R Shimizu ;
T Wada ;
M Ueda ;
M Nobuyoshi ;
I Oh ;
K Sato ;
T Suzuki ;
K Ozaki ;
M Mori ;
T Nagai ;
K Muroi ;
Y Kano ;
Y Furukawa ;
K Ozawa .
Oncogene, 2009, 28 :231-242
[48]   Patterns of the Expression of Cyclin Genes in Bortezomib-Sensitive and Resistant Cells of Multiple Myeloma [J].
Oksuzoglu, E. ;
Dursun, B. .
BIOLOGY BULLETIN, 2022, 49 (SUPPL 2) :S37-S45
[49]   Patterns of the Expression of Cyclin Genes in Bortezomib-Sensitive and Resistant Cells of Multiple Myeloma [J].
E. Oksuzoglu ;
B. Dursun .
Biology Bulletin, 2022, 49 :S37-S45
[50]   Interleukin-6-independent expression of glucocorticoid receptor is upregulated by triptolide in multiple myeloma [J].
Yang, Min ;
Shen, Jia-Kun ;
Huang, Jian ;
Du, Hua-Ping ;
Ma, Qiu-Ling ;
Jin, Jie .
LEUKEMIA & LYMPHOMA, 2009, 50 (05) :802-808